Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarnow

Showing results (791-800 of 848) with videos related to

Pageof 85
Sort By:
Acta Diabetologica|May 18, 2013
CD2AP is associated with end-stage renal disease in patients with type 1 diabetesMervi E Hyvönen, Pekka Ihalmo, Niina Sandholm, et al.
European Journal of Heart Failure|October 30, 2016
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trialAnders Jorsal, Caroline Kistorp, Pernille Holmager, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|November 2, 2021
Neurodevelopmental outcomes of preterm infants after randomisation to initial resuscitation with lower (FiO<sub>2</sub> <u><</u>0.3) or higher (FiO<sub>2</sub> <u>></u>0.6) initial oxygen levels. An individual patient meta-analysisJu Lee Oei, Vishal Kapadia, Yacov Rabi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 24, 2006
Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from GermanyAnke Hinney, Thomas Bettecken, Patrick Tarnow, et al.
Journal of Diabetes Research|July 15, 2015
Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular DysfunctionKarin G F Gerritsen, Jan Willem Leeuwis, Maarten P Koeners, et al.
BMC Endocrine Disorders|July 25, 2019
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and designRikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2007
Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populationsSamy Hadjadj, Lise Tarnow, Carol Forsblom, et al.
Hypertension (Dallas, Tex. : 1979)|March 2, 2005
PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whitesGitte Andersen, Lise Wegner, Dorit Packert Jensen, et al.
Journal of Diabetes and Its Complications|August 4, 2020
Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetesKaroline Winckler, Birger Thorsteinsson, Niels Wiinberg, et al.
Trials|April 4, 2024
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants?Georg M Schmölzer, Elizabeth V Asztalos, Marc Beltempo, et al.
Pageof 85

Showing results (791-800 of 848) with videos related to

Sort By:
Pageof 85
Acta Diabetologica|May 18, 2013
CD2AP is associated with end-stage renal disease in patients with type 1 diabetesMervi E Hyvönen, Pekka Ihalmo, Niina Sandholm, et al.
European Journal of Heart Failure|October 30, 2016
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trialAnders Jorsal, Caroline Kistorp, Pernille Holmager, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|November 2, 2021
Neurodevelopmental outcomes of preterm infants after randomisation to initial resuscitation with lower (FiO<sub>2</sub> <u><</u>0.3) or higher (FiO<sub>2</sub> <u>></u>0.6) initial oxygen levels. An individual patient meta-analysisJu Lee Oei, Vishal Kapadia, Yacov Rabi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 24, 2006
Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from GermanyAnke Hinney, Thomas Bettecken, Patrick Tarnow, et al.
Journal of Diabetes Research|July 15, 2015
Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular DysfunctionKarin G F Gerritsen, Jan Willem Leeuwis, Maarten P Koeners, et al.
BMC Endocrine Disorders|July 25, 2019
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and designRikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2007
Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populationsSamy Hadjadj, Lise Tarnow, Carol Forsblom, et al.
Hypertension (Dallas, Tex. : 1979)|March 2, 2005
PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whitesGitte Andersen, Lise Wegner, Dorit Packert Jensen, et al.
Journal of Diabetes and Its Complications|August 4, 2020
Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetesKaroline Winckler, Birger Thorsteinsson, Niels Wiinberg, et al.
Trials|April 4, 2024
Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants?Georg M Schmölzer, Elizabeth V Asztalos, Marc Beltempo, et al.
Pageof 85